Dapagliflozin ameliorates diabetic renal injury through suppressing the self-perpetuating cycle of inflammation mediated by HMGB1 feedback signaling in the kidney.
Dapagliflozin透過抑制腎臟中由HMGB1反饋信號介導的自我持續炎症循環,改善糖尿病腎損傷。
Eur J Pharmacol 2023-02-23
Canagliflozin ameliorates the development of NAFLD by preventing NLRP3-mediated pyroptosis through FGF21-ERK1/2 pathway.
Canagliflozin透過FGF21-ERK1/2途徑阻止NLRP3介導的焦亡作用,改善NAFLD的發展。
Hepatol Commun 2024-02-12
Nascent shifts in renal cellular metabolism, structure, and function due to chronic empagliflozin in prediabetic mice.
慢性 empagliflozin 對糖尿病前期小鼠腎臟細胞代謝、結構和功能的初期變化。
Am J Physiol Cell Physiol 2024-04-15